In this task, you are given a summary for US Congressional and California state bill, your task is to generate a Title for this bill. The preferred titles are under forty words and mention the purpose of the bill.

[Q]: Reducing Immigration to a Genuinely Healthy Total (RIGHT) Act of 2005 - Reduces U.S. immigration levels (and visa allotments) for: (1) family-sponsored immigrants to zero; (2) diversity immigrants to zero; and (3) employment-based immigrants.

Caps fiscal year humanitarian-related entries at 50,000, which shall include: (1) refugees; (2) assylees; (3) Polish, Hungarian, Soviet, and Indochinese parolees; (4) aliens whose removal is canceled and status adjusted; and (5) aliens provided permanent resident status through private legislation.

Eliminates specified legalization and amnesty programs, including: (1) agricultural worker amnesty; (2) Immigration Reform and Control Act (IRCA) legalizations; (3) amnesties under the Nicaraguan Adjustment and Central American Relief Act of 1997, and the Haitian Refugee and Immigration Fairness Act of 1998; and (4) Cuban-Haitian adjustments.

Requires congressional approval for extension of designation of foreign states for temporary protected status designations.

Establishes as nonimmigrant classifications: (1) spouses and minor children of lawful permanent residents (currently, a preference immigrant classification); and (2) parents of U.S. adult citizens (currently, an immediate relative classification exempt from numerical immigrant limitations).

Prohibits automatic citizenship by birth unless at least one of the individual's parents is, at the time of birth, a U.S. citizen or national or an alien lawfully admitted for permanent residence.

Makes voting in a foreign election a basis for automatic loss of U.S. citizenship.

Sets forth the instances under which illegal U.S. presence by a person shall be considered as not demonstrating good moral character for immigration purposes.
[A]: To reform immigration to serve the national interest.

[Q]: Verifying Authority and Legality In Drug Compounding Act of 2012 - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) with respect to the regulation of compounding drugs.

Eliminates authority for compounding pharmacies to: (1) compound drugs before the receipt of a valid prescription order, or (2) compound any drug product that is a copy of a commercially available drug.

Requires the Secretary of Health and Human Services (HHS) to develop, maintain and transmit to the appropriate state agencies a list of drug products that should not be compounded, including: (1) drug products whose compounding is reasonably likely to cause an adverse effect on their safety or effectiveness; and (2) drug products that have been withdrawn or removed from the market because they have been found to be unsafe or not effective.

Authorizes the Secretary to waive the requirement that a drug product must be compounded for an individually identified patient based on a valid prescription order or similar notation if compounding the drug product is necessary to address a drug shortage, or to protect public health or well-being. Prohibits the Secretary from authorizing a state to grant such waivers.

Authorizes the Secretary to waive the requirement that a drug product must be compounded for an individually identified patient based on a valid prescription order or similar notation if the pharmacy or pharmacist: (1) submits a satisfactory application to the Secretary; and (2) agrees to comply with any condition or limitation specified by the Secretary. Makes a pharmacy or pharmacist required to be registered under the FFDCA as a drug producer ineligible for a waiver. Permits the Secretary to authorize a state to grant such waivers applicable to compounded drug products sold or dispensed within the state pursuant to a memorandum of understanding between the Secretary and the state.

Authorizes the Secretary to waive the prohibition against compounding any drug product that is a copy of a commercially available drug if it is necessary to protect public health or well-being. Prohibits the Secretary from authorizing a state to waive such prohibition.

Subjects the facilities of any pharmacy receiving a waiver under this Act to inspection to determine compliance with this Act.

Requires the Secretary to publish notice at least 30 days before cancelling a waiver, unless it is necessary to prevent an adverse impact on public health or safety.

Sets forth a required label statement for any drug compounded pursuant to this Act.

Requires a pharmacist or physician compounding a drug product to report any adverse event associated with the use of the product within a specified time frame.
[A]: To amend the Federal Food, Drug, and Cosmetic Act to provide for the compounding of drug products.

[Q]: Strengthening Manufacturing and Rebuilding Transit Act of 2011 or SMART Act - Requires the Secretary of Transportation (DOT) to give preference to the award of discretionary or competitive grants, loans, loan guarantees, and lines of credit to transportation infrastructure projects, including the purchase of transit vehicle rolling stock, rail, and supporting equipment, in which manufactured goods to be purchased have a domestic content percentage that: (1) exceeds applicable federal requirements; and (2) in the case of rolling stock, is consistent with industry-recognized standards, if available.

Directs the Secretary to establish a centralized website that provides rules and guidance, waiver notices, and agency actions of the domestic content (Buy America) standards for DOT federal-aid programs.

Requires the Secretary to subject to public notice and comment any request for waiver, and to publication in the Federal Register and notification to Director of the Office of Management and Budget (OMB) of any waiver, of Buy America requirements involving: (1) public transportation projects, (2) AMTRAK acquisition and maintenance of equipment and facilities, and (3) intercity passenger rail service corridor capital assistance projects.

Directs the DOT Inspector General to report annually to Congress on acquisitions funded by federal transportation infrastructure investments that do not comply with Buy American requirements.
[A]:
A bill to improve domestic procurement policies by providing rules and guidance, waiver notices, and departmental and agency actions applicable to the domestic content standards of Federal grants administered by the Department of Transportation, and for other purposes.